Arbor Life Labs develops therapeutics based on stem cell activation via regulation of the Wnt/𝛽-Catenin pathway. Our patent pending platform regulates the Wnt/Beta-Catenin pathway complemented by modulating multiple disease and tissue specific molecular targets. We develop therapeutics to address a range of Aging related Degenerative Conditions to increase Healthspan and Lifespan.We seek partners for product commercialization and development and in the areas of dermatology, regenerative medicine and immunoregulation.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):